Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Charm Care Corporation (6062.T)
JPY1,364.00
+18.00 (+1.34%)
JP JPX Healthcare Medical - Care Facilities
Address
3-6-32 Nakanoshima 530-0005
Osaka, JP
Osaka, JP
CEO
Takahiko Shimomura
Website
charmcc.jp
IPO
2012-04-27
ISIN JP3512740006
Description
Charm Care Corporation specializes in the nursing care industry, operating fee-based residential facilities. The company manages approximately 4,191 rooms across its network of nursing homes, primarily situated in the Tokyo metropolitan and Kinki regions. Established in 1984, the organization initially operated as Fuji Clinic Laboratory before rebranding to Charm Care Corporation in December 2007. Its corporate headquarters are located in Osaka, Japan.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY1,364.00
+18.00 (+1.34%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
98.1K
Beta
0.78
Float Shares
16.67M
Free Float %
51.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.71% | -2.14% | -4.55% | -8.18% | +5.70% | -1.84% | +1.35% | +16.17% | +8.02% | +1,311.23% | +1,605.33% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1,364.00
DCF (Unlevered)
365.52
-73.2%
DCF (Levered)
205.12
-85.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.32
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-2.4% Q1'26: +12.7% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-31.4% Q1'26: +60.2% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+9.0% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+9.6% Q1'26: +10.2% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+16.1% ★ Q1'26: +14.6% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×2.36× ★ Q1'26: 3.01× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 2 Rev. Ana. 2 EPS Ana. |
Jun 2027 1 Rev. Ana. 2 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.93B
est: 11.20B (-2.4%)
|
13.57B
est: 14.00B (-3.1%)
|
16.56B
est: 16.80B (-1.4%)
|
19.62B
est: 19.70B (-0.4%)
|
22.98B
est: 23.30B (-1.4%)
|
29.07B
est: 28.60B (+1.6%)
|
37.89B
est: 39.43B (-3.9%)
|
47.83B
est: 47.00B (+1.8%)
|
46.67B
est: 48.60B (-4.0%)
|
49.05B
49.01B – 49.09B
+0.9% YoY
|
50.50B
50.48B – 50.52B
+3.0% YoY
|
56.05B
56.03B – 56.07B
+11.0% YoY
|
| EBITDA |
1.23B
est: 1.60B (-23.0%)
|
1.43B
est: 2.00B (-28.7%)
|
2.12B
est: 2.40B (-11.8%)
|
2.34B
est: 2.82B (-17.0%)
|
2.85B
est: 3.33B (-14.5%)
|
5.38B
est: 4.09B (+31.4%)
|
5.78B
est: 5.64B (+2.4%)
|
6.31B
est: 6.72B (-6.2%)
|
5.69B
est: 6.95B (-18.1%)
|
7.02B
7.01B – 7.02B
+0.9% YoY
|
7.22B
7.22B – 7.23B
+3.0% YoY
|
8.02B
8.02B – 8.02B
+11.0% YoY
|
| EBIT |
899.62M
est: 1.34B (-32.9%)
|
1.05B
est: 1.68B (-37.3%)
|
1.70B
est: 2.01B (-15.5%)
|
1.89B
est: 2.36B (-19.9%)
|
2.34B
est: 2.79B (-16.1%)
|
4.60B
est: 3.43B (+34.4%)
|
4.92B
est: 4.72B (+4.2%)
|
5.39B
est: 5.63B (-4.3%)
|
4.49B
est: 5.82B (-22.8%)
|
5.88B
5.87B – 5.88B
+0.9% YoY
|
6.05B
6.05B – 6.05B
+3.0% YoY
|
6.71B
6.71B – 6.72B
+11.0% YoY
|
| Net Income |
536.41M
est: 557.24M (-3.7%)
|
615.86M
est: 698.29M (-11.8%)
|
1.01B
est: 1.12B (-10.0%)
|
1.21B
est: 1.28B (-5.9%)
|
1.54B
est: 1.52B (+0.8%)
|
2.95B
est: 2.81B (+5.2%)
|
3.21B
est: 3.77B (-14.9%)
|
4.28B
est: 3.87B (+10.5%)
|
2.94B
est: 4.50B (-34.8%)
|
3.46B
3.40B – 3.52B
-23.1% YoY
|
3.95B
3.75B – 4.14B
+14.0% YoY
|
4.41B
4.40B – 4.41B
+11.6% YoY
|
| SGA |
784.92M
est: 663.08M (+18.4%)
|
1.22B
est: 828.85M (+47.7%)
|
1.13B
est: 994.62M (+13.8%)
|
1.22B
est: 1.17B (+4.3%)
|
1.48B
est: 1.38B (+7.1%)
|
1.77B
est: 1.69B (+4.3%)
|
2.00B
est: 2.33B (-14.5%)
|
2.17B
est: 2.78B (-21.9%)
|
3.40B
est: 2.88B (+18.1%)
|
2.90B
2.90B – 2.91B
+0.9% YoY
|
2.99B
2.99B – 2.99B
+3.0% YoY
|
3.32B
3.32B – 3.32B
+11.0% YoY
|
| EPS |
20.55
est: 17.04 (+20.6%)
|
23.04
est: 21.35 (+7.9%)
|
35.96
est: 34.30 (+4.8%)
|
39.40
est: 39.20 (+0.5%)
|
47.09
est: 46.60 (+1.1%)
|
90.50
est: 85.80 (+5.5%)
|
98.26
est: 115.20 (-14.7%)
|
130.96
est: 118.35 (+10.7%)
|
89.88
est: 137.70 (-34.7%)
|
105.85
104.00 – 107.70
-23.1% YoY
|
120.70
114.70 – 126.70
+14.0% YoY
|
134.70
134.62 – 134.78
+11.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-01 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
3.33B
OE per share TTM
101.94
Owner's Yield
7.72%
Maintenance CapEx ratio
108.50%
Maint CapEx / Avg PPE
33.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 15 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.03% | 132.9K | 0.58% |
| 2 | WisdomTree International Equity Fund DWM | 0.01% | 67.5K | 0.48% |
| 3 | Avantis Global Small Cap Value UCITS ETF AVGS.L | 0.01% | 75.9K | 0.39% |
| 4 | Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L | 0.00% | 34.6K | 0.45% |
| 5 | Dimensional - International Small Cap ETF DFIS | 0.00% | 250.6K | 0.39% |
| 6 | Avantis International Small Cap Equity ETF AVDS | 0.00% | 11.0K | 0.30% |
| 7 | Avantis International Small Cap Value ETF AVDV | 0.00% | 605.5K | 0.36% |
| 8 | Vanguard International Dividend Appreciation ETF VIGI | 0.00% | 261.1K | 0.07% |
| 9 | Avantis Responsible International Equity ETF AVSD | 0.00% | 11.8K | 0.23% |
| 10 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | 22.3K | 0.24% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
2.22M
Shares Outstanding
32.68M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akiko Saito | Executive Officer and GM of Education & Training Department | — | — |
| Hiroshi Kato | Executive Officer & General Manager of Real Estate Business | — | — |
| Shigeki Yokoyama | Executive Officer & Director | — | male |
| Shiro Kokaji | President, Chief Operating Officer & Representative Director | — | male |
| So Kobayashi | General Manager of Sales Division | — | — |
| Takahiko Shimomura | Chairman & Chief Executive Officer | — | male |
| Tomokazu Yamada | Executive Officer & Head of Human Resources Department | — | — |
| Toshifumi Morimoto | Executive Officer & GM of Kinki Metropolitan Area Long-Term Care Business Department | — | — |
| Yoshihiko Maeda | Executive Officer & Director | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 6062.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
